MOESM6 of Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E

Name: MOESM6 of Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E
Published: 2018-11-19T05:00:00Z
Keywords: Tenascin-C, Periostin, Asthma, Type 2 biomarker, Immunoglobulin E, Biochemistry, Space Science, Medicine, Molecular Biology, Physiology, Pharmacology, Immunology, Biological Sciences not elsewhere classified, Developmental Biology

MOESM6 of Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E

2018-11-19T05:00:00Z (GMT) by Mina Yasuda Norihiro Harada Sonoko Harada Ayako Ishimori Yoko Katsura Yukinari Itoigawa Kei Matsuno Fumihiko Makino Jun Ito Junya Ono Kazunori Tobino Hisaya Akiba Ryo Atsuta Kenji Izuhara Kazuhisa Takahashi

Additional file 6: Table S6. Omalizumab-treated patients to divide into 4 groups according to serum TNC and Periostin levels.

MOESM6 of Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E

Categories

Keyword(s)

License

Export